Breakthrough Alpha Radiotherapy

Clinical Trials

Alpha Particles for the Treatment of Cancer

Alpha particles are known to be highly destructive to cancerous cells regardless of their cell cycle stage or level of oxygenation. Alpha particles directly damage the cell DNA, creating complex doublestrand breaks that are lethal to the tumor. However, the short range of alpha particles in tissue had made them rare candidates for treating solid tumors. Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) enables the use of alpha particles for the treatment of solid tumors.

Meir, Skin Cancer Patient (SCC)

“I received the treatment, and after the treatment I went home and came back for checkups. I am very pleased with the treatment given that what had affected my ear has disappeared. I would recommend to patients who don't want to undergo surgery to consider the Alpha DaRT treatment.”


Promising Preliminary Clinical Results

Alpha Tau Medical is currently commencing clinical trials across various indications. Besides the ongoing trial on squamous cell carcinoma of the head, neck and the skin, the company is working with leading cancer researchers on additional protocols of indications such as prostate cancer, breast cancer, gynecological cancer, colorectal cancer and pancreatic cancer.


Please reload

Alpha Tau

Looking for clinical trials?

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon